BioNTech SE BNTX
NASDAQ BNTX
$98.42 -0.15 (-0.15%)
As of: Sep 30, 2026 · 11:59 AM EDT

BioNTech SE (BNTX) Total Non-Current Liabilities (2018 - 2026)

Updated

BioNTech SE (BNTX) posted Total Non-Current Liabilities of $739.15 million for Q2 2026, down 49.1% from $1.45 billion a year earlier but up 3.3% from the prior quarter.

Analysis

BioNTech SE (BNTX) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, BioNTech SE's Total Non-Current Liabilities came in at $724.15 million, up 13.8% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
  • In prior years, BioNTech SE's Total Non-Current Liabilities was $636.24 million in FY2024 (-14.3%), $742.29 million in FY2023 (+166.6%), $278.43 million in FY2022 (-46.6%) and $521.08 million in FY2021 (+33.9%).
  • Quarterly Total Non-Current Liabilities has run from a low of $278.43 million in Q4 2022 to a high of $1.45 billion in Q2 2025 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities increased in four of the last eight quarters, with growth averaging 7.9%.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2023, with growth of 166.6%; the weakest was Q3 2022, with a decline of 53.5%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $715.68 million (Q1 2026), $724.15 million (Q4 2025) and $749.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 BioNTech SE 25.06 Bn -34.31 Bn 10.00 Mn 739.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 739.15 Mn
Mar 31, 2026 715.68 Mn
Dec 31, 2025 724.15 Mn
Sep 30, 2025 749.72 Mn
Jun 30, 2025 1.45 Bn
Mar 31, 2025 758.72 Mn
Dec 31, 2024 636.24 Mn
Sep 30, 2024 839.26 Mn
Jun 30, 2024 796.57 Mn
Mar 31, 2024 741.55 Mn
Dec 31, 2023 742.29 Mn
Sep 30, 2023 580.44 Mn
Jun 30, 2023 544.57 Mn
Mar 31, 2023 282.07 Mn
Dec 31, 2022 278.43 Mn
Sep 30, 2022 339.39 Mn
Jun 30, 2022 427.89 Mn
Mar 31, 2022 599.78 Mn
Dec 31, 2021 521.08 Mn
Sep 30, 2021 729.39 Mn
API Access

BioNTech SE Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BNTX&period=max&api_key=YOUR_API_KEY